Delivery Order 36C24223D0032-36C24225N0240

Award Date 1/1/25
Potential Completion Date 12/31/25
Potential Value $2.4M
Awardee
Sofie CO.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sterling, VA, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, for the supply of PYLARIFY F-18 isotopes. The contract has a ceiling value of $902,180.00 and runs through August 31, 2029. Sofie is a subsidiary of Sofie Biosciences, Inc. and specializes in the development and delivery of molecular diagnostics and therapeutics, particularly radiopharmaceuticals for medical imaging and cancer treatment. The contract supports the...
This federal contract award is to Sofie CO., a subsidiary of Sofie Biosciences, Inc., for the supply of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used for prostate cancer detection. The $1,947,056.48 Firm Fixed Price contract was awarded by the Veterans Integrated Service Network 2 (VISN 2), a division of the Department of Veterans Affairs (VA). The contract has an ultimate completion date of December 31, 2024. Sofie Biosciences, Inc. is a specialized manufacturer and supplier of...
This is a $1,863,815.56 firm fixed-price definitive contract awarded by the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, for the supply of PYLARIFY (piflufolastat F-18 injection), a radiopharmaceutical used for prostate cancer detection. The contract has an ultimate completion date of December 31, 2025 and was awarded on January 1, 2025 without any set-aside designation. Sofie is a subsidiary of Sofie Biosciences, Inc. and has extensive experience providing...
The U.S. Department of Veterans Affairs (VA) awarded a $75,783.12 firm-fixed-price purchase order contract to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the delivery of PYLARIFY, a radiopharmaceutical used in prostate cancer detection. This contract is part of Sofie's broader supply of specialized imaging agents, pharmaceuticals, and related services to various federal agencies, including the VA, Defense Health Agency, and National Institutes of Health. Sofie has...
The Department of Veterans Affairs (VA) awarded a $866,092.80 firm fixed-price purchase order to Sofie CO., a subsidiary of Sofie Biosciences, Inc., for PYLARIFY radiopharmaceuticals. This contract is for the delivery of the PYLARIFY PET imaging agent to support prostate cancer detection programs within the VA's Veterans Integrated Service Network (VISN) 17. Sofie CO. has extensive experience supplying specialized radiopharmaceuticals and related services to various federal agencies, including...
This is a federal contract award from the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract is for the delivery of PET radiopharmaceuticals, which are specialized imaging agents used for medical diagnostics and cancer treatment. The award, valued at $188,258.00, is a delivery order under a larger $5.86 million Indefinite Delivery Vehicle (IDV) contract with the VA's Veterans Integrated Service Network (VISN) 15 for the...
The Department of Veterans Affairs Veterans Health Administration awarded a $176,398.24 firm fixed price purchase order to Sofie CO. for the delivery of the radiopharmaceutical PYLARIFY. The contract has a completion date of May 31, 2022 and does not utilize a set-aside designation. Sofie CO. is a for-profit organization that specializes in developing and delivering molecular diagnostics and therapeutics, with extensive experience in PET imaging. The company has received multiple federal...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S. Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie. The contract, valued at $690,810.00, is for the supply of FDG-F18 radiopharmaceuticals. Sofie is a subsidiary of Sofie Biosciences, Inc. that specializes in the development and delivery of molecular diagnostics and therapeutics, including radiopharmaceuticals for medical imaging and cancer treatment. The...
This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 15 (VISN 15), a component of the U.S. Department of Veterans Affairs (VA), to Sofie CO. (doing business as IBA Molecular) for the supply of PYLARIFY F-18 DCFPYL, a radiopharmaceutical used for prostate cancer detection. The contract has a ceiling value of $1,172,834.00 and an ultimate completion date of May 31, 2026. Sofie CO. is a for-profit organization specializing in the development,...
Sofie Co., a subsidiary of Sofie Biosciences, Inc., was awarded a $453,128 firm fixed price delivery order against the VHA Pharmaceutical Prime Vendor contract to provide Pylarify Piflufolastat F18 radiopharmaceuticals for the Veterans Integrated Service Network 12 region. The one year contract runs from October 2021 through July 2022 and has no set aside designation. The Department of Veterans Affairs Veterans Health Administration will utilize the radiopharmaceuticals in medical imaging...
  • 36C24223D0032
    Indefinite Delivery Contract
  • 36C24223D0032-36C24225N0240
    Delivery Order

This is a delivery order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 2 (VISN 2) to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract, valued at $2,363,711.60, is for the ordering of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used for prostate cancer detection. The contract has a period of performance through December 31, 2025 and is a firm fixed-price contract. Sofie is an established supplier of radiopharmaceuticals and related services to various federal agencies, including the VA, Department of Defense, and National Institutes of Health. This contract supports the VA's medical imaging and cancer treatment programs for veterans across multiple regions. Sofie also holds several Indefinite Delivery Vehicles (IDVs) and Blanket Purchase Agreements (BPAs) with federal agencies for the ongoing supply of its specialized products, further demonstrating its role as a key provider of these critical services.

Generated 12/6/24, 9:27 AM